WHO approval for Bharat Biotech's Covaxin faces further delay: Report

- ‘We are diligently working with the WHO to obtain EUL at the earliest,’ says Bharat Biotech
- Meanwhile, the company had submitted all the data to WHO for Emergency Use Listing of its COVID-19 vaccine Covaxin and is awaiting feedback from the UN Public Health Agency